FDA Inspection 646935 — SpecGx LLC

SpecGx LLC — FEI 1317295

The FDA completed an inspection of SpecGx LLC on January 27, 2010 in Hobart, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hobart, NY (United States)

Citations

IDCFRDescription
115921 CFR 211.28(a)Clothing appropriate for duties performed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
356521 CFR 211.58Buildings not maintained in good state of repair
434021 CFR 211.142Written warehousing procedures established/followed